CardioMech

Designing new therapeutic options for heart disease


The percutaneous approach


CardioMech is developing a catheter-based mitral valve repair technology designed to treat patients suffering from moderate to severe or severe, symptomatic DMR due to prolapse or flail.

The CardioMech technology is designed to provide a catheter-based therapy for the placement of artificial chord(s) to reduce or eliminate MR as an alternative to surgical mitral valve repair.

Caution: The CardioMech device is in the early R&D development phase and is NOT approved or cleared by the FDA or any other regulatory body in any region of the world.


Partners




General inqueries

info@cardiomech.com
CardioMech AS
7030 Trondheim
Norway

CardioMech AS © 2018 · All rights reserved